Aucuparin

CAS No. 3687-28-3

Aucuparin( —— )

Catalog No. M37763 CAS No. 3687-28-3

Aucuparin (2,6-dimethoxy-4-phenylphenol) is a plant antibiotic with anti-inflammatory activity. Aucuparin inhibited pulmonary fibrosis in mouse models induced by bleomycin (BLM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 340 In Stock
2MG 246 In Stock
5MG 366 In Stock
10MG 489 In Stock
25MG 724 In Stock
50MG 958 In Stock
100MG 1293 In Stock
200MG 1739 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Aucuparin
  • Note
    Research use only, not for human use.
  • Brief Description
    Aucuparin (2,6-dimethoxy-4-phenylphenol) is a plant antibiotic with anti-inflammatory activity. Aucuparin inhibited pulmonary fibrosis in mouse models induced by bleomycin (BLM).
  • Description
    Aucuparin (2,6-dimethoxy-4-phenylphenol) is a plant antibiotic with anti-inflammatory activity. Aucuparin inhibited pulmonary fibrosis in mouse models induced by bleomycin (BLM). ABTS and FRAP showed clear scavenging activity. Aucuparin inhibited superoxide production of human neutrophils induced by fmlp, and its IC50 was 17.0μM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    NADPH
  • Recptor
    NADPH-oxidase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    3687-28-3
  • Formula Weight
    230.26
  • Molecular Formula
    C14H14O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O(C)C=1C=C(C=C(OC)C1O)C2=CC=CC=C2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • NQO1 substrate

    NQO1 substrate is a highly potent NQO1 substrate with potential antitumor activity for leukemia research.

  • GKT137831

    GKT137831 (Setanaxib, GKT-137831) is a potent, selective, dual NADPH oxidase Nox1/4 inhibitor with Ki of 110/140 nM.

  • Acetohexamide

    Acetohexamide is a first-generation sulfonylurea medication used to treat diabetes mellitus type 2.